W. Lalouschek et al., 677C TO 677T MUTATION IN THE 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE(MTHFR) GENE AND PLASMA HOMOCYST(E)INE LEVELS IN PATIENTS WITH TIA ORMINOR STROKE, Journal of the neurological sciences, 155(2), 1998, pp. 156-162
It was the aim of this study to determine the associations of clinical
and laboratory data with plasma homocyst(e)ine levels in patients wit
h transient ischemic attack (TIA) or minor stroke (MS), with special r
eference to their 677C to T mutation status in the 5,10-methylenetetra
hydrofolate reductase (5,10-MTHFR) gene. Seventy-six patients with TIA
or MS were investigated at least 3 months after their (last) clinical
event. By means of univariate analysis, significant correlations of h
omocyst(e)ine levels with male gender (P<0.02), age (P<0.0005), creati
nine levels (P<0.0002), folate levels (inversely, P<0.05), and alcohol
use (P<0.02) were found, but not with vitamin B-12 levels. Multivaria
te regression analysis, including age, creatinine levels, and folate l
evels as independent variables, revealed age (P<0.01) and creatinine l
evels (P<0.02) to be significantly correlated with homocyst(e)ine leve
ls. After adjustment for age, creatinine levels and homocyst(e)ine lev
els remained significantly correlated to each other (P<0.005), whereas
the relation between folate levels and homocyst(e)ine levels was no l
onger significant (P=0.10). Mutation-positive patients exhibited moder
ately and statistically non-significantly higher homocyst(e)ine levels
than mutation-negative patients, particularly those who were homozygo
us positive. Homocyst(e)ine levels were closely correlated with creati
nine levels (P<0.0002) and with folate levels (inversely, P<0.05), but
only in mutation-positive and not in mutation-negative patients. Homo
zygous positive, heterozygous positive, and mutation-negative patients
did not differ with respect to clinical and laboratory data concernin
g 'risk factors for stroke' or co-existing vascular disease. In conclu
sion, the associations of creatinine levels and, inversely, of folate
levels with plasma homocyst(e)ine levels in patients with TIA or MS ar
e dependent on the 5,10-MTHFR mutation status. Significant correlation
s between these variables were found only in mutation-positive but not
in mutation-negative patients. (C) 1998 Elsevier Science B.V.